Isothermal Nucleic Acid Amplification Technology Global Market Report 2023: Recent Launches of INAAT Consumables by Prominent Market Players Fuel Growth

DUBLIN, March 23, 2023 /PRNewswire/ -- The "Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028" report has been added to  ResearchAndMarkets.com's offering.

The isothermal nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period.

Increasing prevalence of infectious diseases, launches & approvals for INAAT products and availability of funding for diagnostic tools are various factors projected to drive the growth of the isothermal nucleic acid amplification technology market.

LAMP segment accounted for the largest share of the INAAT market

Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. In 2022, the loop-mediated isothermal amplification (LAMP) segment dominated the market. This is owing to high demand for LAMP kits and wide availability of these kits in developed and developing markets across the globe.

Infectious disease diagnosis segment accounted for the largest application segment of the market

Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are rising number of HIV, influenza, and hepatitis cases across the globe, focus on infectious disease control, and use of INAAT based kits for the diagnosis of these diseases.

North America: Accounted for the largest share in the isothermal nucleic acid amplification technology market

North America has the largest share of the isothermal nucleic acid amplification technology market. Factors such as availability of research funding and the development of diagnostic industry, increasing importance of early diagnosis for patient with HIV, Hepatitis and Influenza, and developed healthcare infrastructure are the major factors driving the market growth.

Market Dynamics

Drivers

• Recent Launches of INAAT Consumables by Prominent Market Players
• Growing Funding Initiatives for Molecular Diagnostics & Infectious Disease Diagnostics
• High Prevalence of Infectious Diseases

Restraints

• Unfavorable Reimbursement Scenario for in Vitro Diagnostic Tests

Opportunities

• INAAT Tests as Point-Of-Care Tools
• Start-Ups Focusing on INAAT

Challenges

• Dominance of PCR

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Isothermal Nucleic Acid Amplification Technology Market, by Product
6.1 Introduction
Table 11 Market, by Product, 2021-2028 (USD Million)
6.2 Assays, Kits, and Reagents
6.3 Systems

7 Isothermal Nucleic Acid Amplification Technology Market, by Technology
7.1 Introduction
7.2 Loop-Mediated Isothermal Amplification (Lamp)
7.3 Transcription-Mediated Amplification (Tma)
7.4 Nicking Enzyme Amplification Reaction (Near)
7.5 Strand Displacement Amplification (SDA)
7.6 Helicase-Dependent Amplification (Hda)
7.7 Nucleic Acid Sequence-based Amplification (NASBA)
7.8 Single-Primer Isothermal Amplification (Spia)
7.9 Other Technologies

8 Isothermal Nucleic Acid Amplification Technology Market, by Application
8.1 Introduction
Table 54 Market, by Application, 2021-2028 (USD Million)
8.2 Disease Diagnosis
8.3 Blood Screening
8.4 Other Applications

9 Isothermal Nucleic Acid Amplification Technology Market, by End-user
9.1 Introduction
9.2 Hospitals
9.3 Reference Laboratories
9.4 Academic & Research Institutes
9.5 Other End-users

10 Isothermal Nucleic Acid Amplification Technology Market, by Region

11 Competitive Landscape

12 Company Profiles

13 Appendix

Companies Mentioned

• Abbott Laboratories
• Atila Biosystems
• Becton, Dickinson and Company
• Biomerieux SA
• Diasorin S.P.A.
• Eiken Chemical Co. Ltd.
• General Electric Company
• Genomtec
• Genosensor Corporation
• Grifols, SA
• Hologic, Inc.
• Jena Bioscience GmbH
• Lgc Limited
• Life Sciences Advanced Technologies
• Mast Group Ltd.
• Meridian Bioscience
• New England Biolabs
• Optigene Limited
• Pcr Biosystems
• Qiagen N.V.
• Quidel Corporation
• Tecan Trading Group
• Thermo Fisher Scientific
• Twistdx Limited
• Ustar Biotechnologies

For more information about this report visit https://www.researchandmarkets.com/r/vc64wc

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets